AxoGen (AXGN)
(Delayed Data from NSDQ)
$12.67 USD
-0.42 (-3.21%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $12.66 -0.01 (-0.08%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth C Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
AXGN 12.67 -0.42(-3.21%)
Will AXGN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AXGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AXGN
Will PROCEPT BioRobotics Corporation (PRCT) Report Negative Earnings Next Week? What You Should Know
AxoGen (AXGN) Earnings Expected to Grow: Should You Buy?
AXGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
AxoGen (AXGN) Loses 25.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Solventum Stock Gains on Q1 Earnings & Revenue Beat, Margins Decline
MCK Stock Up on Q4 Earnings Beat & Potential Surgical Biz Spin-Off
Other News for AXGN
Axogen (AXGN) Considers Potential Sale Amid Acquisition Interest
Axogen gains on report of takeover interest
AxoGen exploring possible sale after approach, Street Insider says
Axogen (AXGN) Considers Potential Sale Amid Takeover Proposal
Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth Conference | AXGN Stock News